Lifeward (LFWD) Cash from Financing Activities (2015 - 2026)
Lifeward's (LFWD) quarterly Cash from Financing Activities came in at $6.4 million in Q1 2026, up 43.64% year-on-year from $4.5 million in Q1 2025, and up 69.98% quarter-over-quarter from $3.8 million in Q4 2025.
Lifeward (LFWD) Cash from Financing Activities (2015 - 2026) Analysis & Trends
Lifeward has disclosed Cash from Financing Activities across 11 years of filings, most recently posting $6.4 million for Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at $6.4 million, up 43.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.2 million (up 216.57% YoY), and the FY2025 annual result was $12.2 million, changed N/A from the prior year.
- Cash from Financing Activities came in at $6.4 million for Q1 2026 at Lifeward, up from $3.8 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $6.4 million in Q1 2026 to a low of -$2.3 million in Q4 2022.
- The 4-year median for Cash from Financing Activities is $320000.0 (2023), against an average of $1.5 million.
- Across the five-year window, Cash from Financing Activities plunged 682.77% in 2022 and jumped 96.72% in 2023, its largest moves.
- Lifeward's Cash from Financing Activities stood at -$2.3 million in 2022, then jumped by 99.74% to -$6000.0 in 2023, then jumped by 63066.67% to $3.8 million in 2025, then soared by 69.98% to $6.4 million in 2026.
- The last three Cash from Financing Activities figures came in at $6.4 million (Q1 2026), $3.8 million (Q4 2025), and $646000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Lifeward | 11.14 Mn | -263,371.13 | 1.34 Mn | 6.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.42 Mn |
| Mar 31, 2026 | 6.42 Mn |
| Dec 31, 2025 | 3.78 Mn |
| Dec 31, 2025 | 3.78 Mn |
| Sep 30, 2025 | 646,000.00 |
| Sep 30, 2025 | 646,000.00 |
| Jun 30, 2025 | 3.31 Mn |
| Jun 30, 2025 | 3.31 Mn |
| Mar 31, 2025 | 4.47 Mn |
| Mar 31, 2025 | 4.47 Mn |
| Sep 30, 2023 | -6,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Jun 30, 2023 | -215,000.00 |
| Jun 30, 2023 | -215,000.00 |
| Mar 31, 2023 | -771,000.00 |
| Mar 31, 2023 | -771,000.00 |
| Dec 31, 2022 | -2.32 Mn |
| Dec 31, 2022 | -2.32 Mn |
| Sep 30, 2022 | -183,000.00 |
| Sep 30, 2022 | -183,000.00 |